Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.53
-$0.01-1.13%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.02M | -16.63M | -19.86M | -22.76M | -27.11M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.70M | 1.87M | 2.14M | 2.29M | 2.08M |
| Change in Net Operating Assets | -5.98M | -5.44M | -6.87M | -7.43M | -1.52M |
| Cash from Operations | -17.30M | -20.20M | -24.59M | -27.90M | -26.55M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 406.90K | 406.90K | 406.90K | 561.90K | 561.90K |
| Total Debt Repaid | -376.00K | -399.90K | -458.20K | -645.00K | -656.30K |
| Issuance of Common Stock | 26.90M | 37.10M | 25.61M | 35.60M | 30.83M |
| Repurchase of Common Stock | -97.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.83M | 37.10M | 25.56M | 35.52M | 30.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.53M | 16.90M | 962.40K | 7.62M | 4.19M |